caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1548211899

Arsine BarsegyanM.D.

Internal MedicineGlendale, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Arsine Barsegyan's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 11 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
ALLSTATE INVESTMENT REALTY INC2111,110
DIGNITY COMMUNITY CARE58169
Unilab Corporation
Clinical Laboratory · West Hills, CA
2574
LEVINE, STEPHEN2074
Yuri Busi
Cardiology · Glendale, CA
1650
Haroutioun Mesrobian
Cardiology · Glendale, CA
1341
Primex Clinical Laboratories Inc.
Clinical Laboratory · Van Nuys, CA
1333
Haroutun Hovanesian
Ophthalmology · Glendale, CA
1246
PROVIDENCE HEALTH SYSTEM - SOUTHERN CALIFORNIA1142
Don Lee
Interventional Cardiology · Glendale, CA
1139
Daniel Goodwin
Cardiology · Portland, OR
1131
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,411
Unique beneficiaries
—
Total services
4,692
Distinct HCPCS
14
Medicare payment
$282K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 10,499 Internal Medicine providers in CA — top quintile (cohort median 531).
QUALITY · MIPS · 2024
Final MIPS score
75.0
Quality
0.0
Cost
30.1
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
0.00%
Individual
PRESCRIBING · PART D · 2024
Total Rx claims
29,842
Beneficiaries
—
Total drug cost
$1.8M
Distinct drugs
203
Brand share
22.2%
Top prescribed drugs
Ibuprofen1,397 claims
Gabapentin1,055 claims
Icosapent Ethyl1,039 claims
Rosuvastatin Calcium1,003 claims
Amlodipine Besylate923 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$212
Payment records
8
By payment type
Food and Beverage$147
Education$65